Seed VC · USA

Domain Associates

Active

What they invest in

Investment advisors to the first VC fund dedicated to biotech, managing subsequent biotech VC funds focused on biopharm, device and diagnostic companies.

Who they back

DeepTechHealthtechBiotechSeedSeries ASeries B+

Business models

deeptech_ip, biotech_therapeutics

Customer segments

Researchers

Geography

US

The people who write checks

8 partners on file at Domain Associates, with the firm's email pattern for cold outreach. Score your deck (free, 30 seconds) to unlock direct contact for this firm and 47,000+ others.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Domain Associates writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Domain Associates alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
United States
Last known deal
Dec 2016
Portfolio last checked
Oct 6, 2026
Website
www.domainvc.com ↗

Other firms investing in DeepTech

See all investors

Is Domain Associates the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Domain Associates is one of them, and we'll tell you exactly where they sit in your top 100.